What is Landry & Swarr?
Headquartered in New Orleans, Louisiana, Landry & Swarr operates as a high-stakes litigation firm with a specialized focus on mesothelioma and asbestos-related disease claims. With a legacy spanning over two decades, the firm has cultivated a reputation for rigorous advocacy in cases involving toxic chemical exposure and complex lung cancer litigation. Their business model centers on a client-centric approach, providing comprehensive legal support to families navigating the aftermath of industrial health crises. By maintaining a deep focus on toxic torts, the firm has established itself as a critical player in the regional legal landscape, ensuring that victims receive the necessary representation to secure equitable settlements.
How much funding has Landry & Swarr raised?
Landry & Swarr has raised a total of $405K across 2 funding rounds:
Debt
$150K
Debt
$255K
Debt (2020): $150K with participation from PPP
Debt (2021): $255K led by PPP
Key Investors in Landry & Swarr
PPP
Public-Private Partnership
What's next for Landry & Swarr?
With the recent influx of capital, Landry & Swarr is positioned to scale its litigation infrastructure and enhance its capacity for handling complex, multi-jurisdictional asbestos claims. The firm's strategic roadmap likely involves the integration of advanced case management technologies and the expansion of its legal team to address the growing demand for specialized toxic tort representation. As the firm moves into this next phase of growth, the focus will remain on optimizing settlement outcomes and strengthening its footprint in the Louisiana legal market. This late-stage financing provides the necessary liquidity to sustain long-term litigation efforts, ensuring that the firm remains at the forefront of environmental and occupational health advocacy.
See full Landry & Swarr company page
